Showing results (161-170 of 203) with videos related to
Sort By:
Pageof 21
Bioinformatics (Oxford, England)|July 7, 2026
Inferring and evaluating network medicine-based disease modules with nextflowJohannes Kersting, Chloé Bucheron, Lisa M Spindler, et al.Research Square|May 19, 2025
IBDome: An integrated molecular, histopathological, and clinical atlas of inflammatory bowel diseasesZlatko Trajanoski, Christina Plattner, Gregor Sturm, et al.Blood Advances|May 27, 2026
DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell LeukemiaJan-Paul Bohn, Alexandra Scheiber, Gregor Sturm, et al.The Journal of Allergy and Clinical Immunology|September 29, 2024
Persistent desmoglein-1 downregulation and periostin accumulation in histologic remission of eosinophilic esophagitisHannes Hoelz, Tim Faro, Marie-Luise Frank, et al.Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.Nature Communications|July 16, 2020
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposingSepideh Sadegh, Julian Matschinske, David B Blumenthal, et al.Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.Cell Reports. Medicine|July 16, 2025
Endoscopic healing in pediatric IBD perpetuates a persistent signature defined by Th17 cells with molecular and microbial drivers of diseaseKolja Siebert, Tim Faro, Nikolai Köhler, et al.Pageof 21